FGF23 Trajectories in Children and Association with CKD Progression: The Chronic Kidney Disease in Children Study.
Academic Article
Overview
abstract
BACKGROUND: In children and adults, plasma Fibroblast Growth Factor 23 (FGF23) concentrations increase early in chronic kidney disease (CKD) and associate with disease progression and adverse cardiovascular outcomes. However, longitudinal changes in FGF23 in children with progressive CKD are not well characterized. METHODS: We measured C-terminal FGF23 biannually and estimated Glomerular Filtration Rate (eGFR) in 543 children with CKD stages 2-4 enrolled in the Chronic Kidney Disease in Children study. All participants had 2-3 FGF23 measurements. We used a linear mixed model to estimate the average percent change in FGF23 and eGFR over time for the overall cohort and latent group-based trajectory modeling to identify populations with distinct patterns of change in FGF23 concentration, eGFR and phosphorus z-score. We used Cox proportional hazards model to examine the risk of progression to kidney failure according to FGF23 trajectory group. RESULTS: At study enrollment, median age was 12 years and eGFR 52 ml/min/1.73m2. In univariate models with repeated measures, FGF23 increased by a mean of 3.7% annually, and eGFR decreased by 3.8% annually over a median observation period of four years. We identified three distinct FGF23 trajectories: stable in 64% of participants (FGF23 slope 0% per yr); slowly rising in 30% (slope 6% per year) and rapidly rising in 6% (slope 39% per year). Membership in the faster-rising trajectory groups was associated with lower eGFR, higher serum phosphorus, greater proteinuria, and anemia. With subsequent median 4.9 years of follow-up, the risk of kidney failure was 1.7-fold higher (95% CI, 1.09 to 2.67) in the slowly rising and 8-fold higher (95% CI, 2.41 to 23.56) in the rapidly rising FGF23 trajectory group compared with the stable trajectory group, in fully adjusted analyses. Phosphorus z-score trajectories did not associate with progression to kidney failure in adjusted models. CONCLUSION: By characterizing longitudinal changes in FGF23 in children with CKD, we find that FGF23 was stable in most children. Membership in the faster-rising FGF23 trajectory groups associates with increased risk of progression to kidney failure. Future studies are needed to investigate whether FGF23 is a modifiable cause or a consequence of CKD progression in children with CKD.
